Elizabeth Barrett - Jun 18, 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Earl Douglas, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jun 18, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 09:03 PM
Previous filing
Jun 13, 2025
Next filing
Jul 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Barrett Elizabeth A. Director 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO /s/Earl Douglas, Attorney-in-Fact 2025-06-20 0001764157

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Restricted Stock Unit Award $0 +95.4K $0.00 95.4K Jun 18, 2025 Common Stock 95.4K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Barrett has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.

Remarks:

Exhibits: Power of Attorney